SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 12, 2026

PCRX

Pacira BioSciences, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $372K total
Actionable Insight • Neutral

The insider sales are too small to signal any material concern.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$22.74
T+0 close · Jun 12, 2026 · via day close
Latest settled
+13.81%
T+60 · $25.88
Vs SPY
+12.81%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 15 $22.74entry
  2. T+1 · 5mo ago +0.35%α +0.95% · $22.82
  3. T+5 · 5mo ago −0.13%α +1.25% · $22.71
  4. T+20 · 4mo ago +12.31%α +13.06% · $25.54
  5. T+60 · 2mo ago +13.81%α +12.81% · $25.88
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Pacira BioSciences saw two insider sales totaling $372K over a week, including the Chief Administrative Officer and SVP of Finance. The total value is 0.04% of the $905M market cap, which is trivial. The cluster is dominated by non-cash director grants ($0 value) that carry no economic signal, making the selling activity routine and non-informative.

Key Financial Metrics

Direction
selling
Total Value
$372.0K
Insiders
2

Key Facts

  • Two insiders sold shares: CAO Kristen Williams ($228K) and SVP Finance Lauren Riker ($144K), total $372K.
  • Total selling value is 0.04% of $905M market cap, trivial and routine.
  • 14 director grants (non-cash, $0 value) occurred on 2026-06-10, representing standard equity compensation, not a trading signal.

Financial Impact

Insider sales of $372K represent 0.04% of market cap, immaterial.

dilution

Risk Factors

  • No material insider buying to offset the selling pattern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCRX-1781312904049

Track record

29 reports on PCRX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +42.26% at T+60 after the Aug 6, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Bearish 6/10 Entry $36.46 Now $36.48 −0.05% settles Dec 14
  2. Nov 12, 20264d ago SC TO-T/A Mixed 7/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
  3. Nov 12, 20264d ago SC 14D-9/A Neutral 3/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
  4. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $36.43 Now $36.48 +0.14% settles Dec 7
  5. Nov 3, 202613d ago SC 14D-9/A Neutral 3/10 Entry $36.40 Now $36.48 +0.22% settles Dec 3
  6. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
  7. Oct 30, 202617d ago SC 14D-9 Bullish 7/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
  8. Oct 30, 202617d ago SC TO-T Mixed 7/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
  9. Oct 13, 20264w ago SC 13D/A Bearish 7/10 Entry $36.40 to $36.46 Now $36.48 −0.22% ▼ −0.16% −1.44% vs SPY
  10. Oct 8, 20265w ago SC TO-C Bullish 7/10 Entry $36.31 to $36.43 Now $36.48 +0.47% ▲ +0.33% +5.89% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 7h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026